"The new ANGIODIN version successfully passed the technical tests, increasing the diagnosis possibilities of the old version, which only detected arterial problems," said PhD. Manuel Arsenio Lores Guevara, director of the CMB, a prestigious institution that will turn 15 years next February 10.
Read More